ES2564143T8 - Nuevas formas y sales de un inhibidor dihidropirrolo[1,2-c]imidazolilo de aldosterona sintasa o aromatasa - Google Patents

Nuevas formas y sales de un inhibidor dihidropirrolo[1,2-c]imidazolilo de aldosterona sintasa o aromatasa

Info

Publication number
ES2564143T8
ES2564143T8 ES13701194T ES13701194T ES2564143T8 ES 2564143 T8 ES2564143 T8 ES 2564143T8 ES 13701194 T ES13701194 T ES 13701194T ES 13701194 T ES13701194 T ES 13701194T ES 2564143 T8 ES2564143 T8 ES 2564143T8
Authority
ES
Spain
Prior art keywords
dihydropyrrolo
aromatase
imidazolyl
inhibitor
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13701194T
Other languages
English (en)
Other versions
ES2564143T3 (es
Inventor
Paul Sutton
Eric Loeser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2564143(T8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2564143T3 publication Critical patent/ES2564143T3/es
Publication of ES2564143T8 publication Critical patent/ES2564143T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES13701194.6T 2012-01-17 2013-01-15 Nuevas formas y sales de un inhibidor dihidropirrolo[1,2-c]imidazolilo de aldosterona sintasa o aromatasa Active ES2564143T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
US201261587280P 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (2)

Publication Number Publication Date
ES2564143T3 ES2564143T3 (es) 2016-03-18
ES2564143T8 true ES2564143T8 (es) 2020-11-18

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13701194.6T Active ES2564143T3 (es) 2012-01-17 2013-01-15 Nuevas formas y sales de un inhibidor dihidropirrolo[1,2-c]imidazolilo de aldosterona sintasa o aromatasa

Country Status (41)

Country Link
US (2) US9334276B2 (es)
EP (1) EP2804863B1 (es)
JP (1) JP5749410B2 (es)
KR (2) KR20140141687A (es)
CN (1) CN104039793B (es)
AP (1) AP2014007762A0 (es)
AR (1) AR089728A1 (es)
AU (1) AU2013209952B2 (es)
BR (1) BR112014017260A8 (es)
CA (1) CA2863339C (es)
CL (1) CL2014001863A1 (es)
CO (1) CO7000775A2 (es)
CR (1) CR20140345A (es)
CU (1) CU20140086A7 (es)
CY (1) CY1117914T1 (es)
DK (1) DK2804863T3 (es)
EA (1) EA026232B1 (es)
ES (1) ES2564143T3 (es)
GT (1) GT201400155A (es)
HK (1) HK1198536A1 (es)
HR (1) HRP20160178T1 (es)
HU (1) HUE026984T2 (es)
IL (1) IL233541B (es)
IN (1) IN2014DN06781A (es)
JO (1) JO3137B1 (es)
MA (1) MA35858B1 (es)
MX (1) MX2014008686A (es)
NZ (1) NZ626277A (es)
PE (1) PE20142358A1 (es)
PH (1) PH12014501638B1 (es)
PL (1) PL2804863T3 (es)
RS (1) RS54589B1 (es)
SG (1) SG11201404061YA (es)
SI (1) SI2804863T1 (es)
SM (1) SMT201600083B (es)
TN (1) TN2014000256A1 (es)
TW (1) TWI609869B (es)
UA (1) UA114803C2 (es)
UY (1) UY34576A (es)
WO (1) WO2013109514A1 (es)
ZA (1) ZA201404314B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101412206B1 (ko) * 2010-01-14 2014-06-25 노파르티스 아게 부신 호르몬 조절제의 용도
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
JP6731136B2 (ja) 2014-07-07 2020-07-29 レコルダティ アーゲー 医薬製剤
HUE054248T2 (hu) 2015-01-29 2021-08-30 Recordati Ag Eljárás kondenzált imidazo-származékok elõállítására
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
KR102506380B1 (ko) * 2016-10-27 2023-03-03 다미안 파르마 에이쥐 알도스테론 합성효소 저해제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
AU668708B2 (en) 1992-01-27 1996-05-16 Janssen Pharmaceutica N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
JP2006508970A (ja) * 2002-11-18 2006-03-16 ノバルティス アクチエンゲゼルシャフト イミダゾ[1,5a]ピリジン誘導体およびアルデステロンにより仲介される疾患の処置方法
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
WO2008076862A2 (en) 2006-12-18 2008-06-26 Novartis Ag 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
JP5575913B2 (ja) 2009-11-30 2014-08-20 ノバルティス アーゲー アルドステロン合成酵素阻害剤としてのイミダゾール誘導体
KR101412206B1 (ko) * 2010-01-14 2014-06-25 노파르티스 아게 부신 호르몬 조절제의 용도

Also Published As

Publication number Publication date
CU20140086A7 (es) 2014-12-26
EA026232B1 (ru) 2017-03-31
US20140364470A1 (en) 2014-12-11
CN104039793B (zh) 2017-05-10
MX2014008686A (es) 2014-08-27
CY1117914T1 (el) 2017-05-17
ES2564143T3 (es) 2016-03-18
UY34576A (es) 2013-09-02
TN2014000256A1 (en) 2015-09-30
AU2013209952B2 (en) 2016-09-01
MA35858B1 (fr) 2014-12-01
JP5749410B2 (ja) 2015-07-15
IN2014DN06781A (es) 2015-05-22
HRP20160178T1 (hr) 2016-03-25
SI2804863T1 (sl) 2016-05-31
TW201335161A (zh) 2013-09-01
IL233541A0 (en) 2014-08-31
HK1198536A1 (en) 2015-05-15
US9334276B2 (en) 2016-05-10
CL2014001863A1 (es) 2014-11-07
US20160176883A1 (en) 2016-06-23
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
AP2014007762A0 (en) 2014-07-31
SG11201404061YA (en) 2014-08-28
PH12014501638A1 (en) 2014-10-13
PH12014501638B1 (en) 2014-10-13
EP2804863B1 (en) 2015-12-02
WO2013109514A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
RS54589B1 (en) 2016-08-31
CA2863339A1 (en) 2013-07-25
CR20140345A (es) 2014-09-09
KR20140141687A (ko) 2014-12-10
BR112014017260A2 (pt) 2017-06-13
AR089728A1 (es) 2014-09-10
JP2015503627A (ja) 2015-02-02
PE20142358A1 (es) 2015-01-30
GT201400155A (es) 2017-09-28
ZA201404314B (en) 2015-08-26
DK2804863T3 (en) 2016-03-07
NZ626277A (en) 2015-10-30
EP2804863A1 (en) 2014-11-26
KR20140093726A (ko) 2014-07-28
PL2804863T3 (pl) 2016-06-30
CA2863339C (en) 2021-03-23
UA114803C2 (uk) 2017-08-10
AU2013209952A1 (en) 2014-07-24
HUE026984T2 (en) 2016-08-29
CO7000775A2 (es) 2014-07-21
SMT201600083B (it) 2016-04-29
IL233541B (en) 2018-12-31
JO3137B1 (ar) 2017-09-20
TWI609869B (zh) 2018-01-01

Similar Documents

Publication Publication Date Title
HK1210696A1 (en) Irak inhibitors and uses thereof irak
HK1209632A1 (en) Irak inhibitors and uses thereof -1 (irak)
CO7000775A2 (es) Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa
HK1245668A1 (zh) 微小rna抑制劑
HK1210732A1 (en) Irak inhibitors and uses thereof irak
BR112014030410A2 (pt) inibidores de pirazolopirimidona e pirazolopiridona de tanquirase
IL232611A0 (en) Di-converted benzothianyl-pyrrolotriazines and their use as fgfr kinase inhibitors
EP2663312A4 (en) IRAQ INHIBITORS AND THEIR USE
AP4029A (en) Inhibitors of beta-secretase
HRP20180543T1 (hr) Spojevi uree i njihova upotreba kao inhibitora enzima
IL236963A0 (en) beta-secretase inhibitors
ZA201407940B (en) Inhibitor of jak1 and jak2
GB201219678D0 (en) Ketone body inhibitors and uses thereof
EP2716292A4 (en) CDC42 INHIBITOR AND USES THEREOF
GB201207768D0 (en) Corrosion inhibitor
ES1072502Y (es) Recubrimiento antideslizante